DB
HRMY icon

Danske Bank’s Harmony Biosciences HRMY Stock Holding History

Danske Bank’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-16,909
Closed -$466K – 1597
2025
Q3 		$466K Sell
16,909
-9,553
-36% -$329K ﹤0.01% 777
2025
Q2 		$836K Sell
26,462
-20,230
-43% -$651K ﹤0.01% 731
2025
Q1 		$1.55M Buy
46,692
+596
+1% +$21.4K ﹤0.01% 740
2024
Q4 		$1.59M Buy
46,096
+15,792
+52% +$543K ﹤0.01% 753
2024
Q3 		$1.21M Buy
30,304
+7,083
+31% +$249K ﹤0.01% 783
2024
Q2 		$701K Buy
+23,221
New +$698K ﹤0.01% 822

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Danske Bank's HRMY Position: Q4 2025 in Review

Danske Bank sold out of Harmony Biosciences (HRMY) in Q4 2025, closing a stake of 16,909 shares — an estimated $466K sold.

Danske Bank first reported a position in HRMY in Q2 2024 and held it in 6 quarters. The position peaked at $1.59M in Q4 2024. 325 funds tracked by Wall St. Rank hold HRMY as of Q4 2025.

  • Danske Bank reported no remaining Harmony Biosciences position as of Q4 2025 after selling out during the quarter.
  • Danske Bank sold 16,909 Harmony Biosciences shares in Q4 2025, an estimated $466K.
  • Danske Bank first reported a position in Harmony Biosciences in Q2 2024 and held it in 6 quarters.
  • Danske Bank's Harmony Biosciences position peaked at $1.59M in Q4 2024.
  • 325 funds tracked by Wall St. Rank held Harmony Biosciences as of Q4 2025.

Based on Danske Bank's 13F filing for Q4 2025, filed 2 Feb 2026.